Oracle CORP Form 4 insider transactions
NYSE
ORCL
Oracle CORPForm 4: Oracle CEO Safra Catz Exercises and Sells Over 3.7 Million Shares Under Pre-Planned Trading Program
Oracle Chief Executive Officer Safra Catz executed significant stock option exercises and subsequent sales of over 3.7 million shares of Oracle common stock in late June 2025, as part of a pre-arranged Rule 10b5-1 trading plan.
NYSE
ORCL
Oracle CORPOracle Executive Chairman and CTO Lawrence J. Ellison has acquired 5 million performance-based stock options, vesting upon the Compensation Committee's certification of a performance goal.
NYSE
ORCL
Oracle CORPOracle Vice Chairman and Director Jeffrey Henley disclosed gifting 147,000 shares of Oracle common stock on June 23, 2025, as detailed in a recent SEC Form 4 filing.
NYSE
ORCL
Oracle CORPForm 4: Oracle CEO Safra Catz Exercises and Sells Over 3.6 Million Shares Under Pre-Planned Trading Program
Oracle Corporation CEO Safra Catz executed significant stock option exercises and subsequent sales of over 3.6 million shares, realizing substantial profits under a pre-arranged Rule 10b5-1 trading plan.
NYSE
ORCL
Oracle CORPOracle Corporation Director George H. Conrades has sold 8,169 shares of common stock for approximately $1.74 million in a pre-arranged transaction.
NYSE
ORCL
Oracle CORPClayton M. Magouyrk, President of Oracle Cloud Infrastructure (OCI), sold 15,000 shares of Oracle Corp. common stock for approximately $3.2 million, executed under a Rule 10b5-1 trading plan.
NYSE
ORCL
Oracle CORPForm 4: Oracle Vice Chairman Jeffrey Henley Executes Pre-Planned Stock Option Exercise and Share Sale
Oracle Corporation's Vice Chairman and Director, Jeffrey Henley, completed a pre-arranged exercise of stock options and subsequent sale of 400,000 shares of common stock on June 12, 2025, under a Rule 10b5-1 trading plan.
NYSE
ORCL
Oracle CORPOracle Corp. Director William G. Parrett reported the acquisition of 2,986 shares of common stock through Restricted Stock Unit conversion and the grant of 2,114 new Restricted Stock Units.
NYSE
ORCL
Oracle CORPOracle Corporation Director Bruce R. Chizen has reported recent transactions involving the acquisition of common stock and restricted stock units, increasing his direct and indirect beneficial ownership.
NYSE
ORCL
Oracle CORPOracle Director Naomi O. Seligman reported the acquisition of common stock through Restricted Stock Unit (RSU) conversion and the disposition of a larger block of common stock, alongside a new RSU grant.
NYSE
ORCL
Oracle CORPOracle Corporation Director Leon E. Panetta has reported the acquisition of 2,986 shares of common stock through the settlement of restricted stock units and the grant of an additional 2,114 restricted stock units, as detailed in a recent SEC Form 4 filing.
NYSE
ORCL
Oracle CORPOracle Corp. Director Charles W. Moorman reported the acquisition of common stock through restricted stock unit vesting and the disposition of a significant number of shares, as detailed in a recent SEC Form 4 filing.
NYSE
ORCL
Oracle CORPOracle Director Rona Alison Fairhead reported the acquisition of common stock through RSU vesting and the disposition of shares for tax purposes, along with new RSU grants, as detailed in a recent Form 4 filing.
NYSE
ORCL
Oracle CORPOracle Director George H. Conrades reported the sale of 46,625 shares of common stock, alongside the exercise of 2,986 restricted stock units and the grant of 2,114 new restricted stock units.
NYSE
ORCL
Oracle CORPOracle Corp. Director Michael J. Boskin reported the exercise of restricted stock units, acquisition of new units, and a substantial sale of common stock on May 31, 2025.
NYSE
ORCL
Oracle CORPOracle Corporation Director Jeffrey Berg has reported the acquisition of 2,986 shares of common stock through the conversion of restricted stock units and an additional 2,114 restricted stock units, executed under a pre-arranged trading plan.
NYSE
ORCL
Oracle CORPForm 4: Oracle Director Ablo Awo Reports Routine Equity Transactions Including RSU Vesting and New Grant
Oracle Corporation Director Ablo Awo reported the conversion of restricted stock units into common stock, a new RSU grant, and shares withheld for tax liability, as detailed in a recent SEC Form 4 filing.
NYSE
ORCL
Oracle CORPDirector Jeffrey Berg reports a gift of Oracle common stock and details beneficial ownership, including shares held directly, in a family trust, and by a spouse.
NYSE
ORCL
Oracle CORPNaomi Seligman, a director at Oracle, sold 2,866 shares of common stock on May 5, 2025, at a weighted average price of $149.533 per share.
NYSE
ORCL
Oracle CORPDirector Leon Panetta exercised stock options and sold shares of Oracle Corp on May 2, 2025.
NYSE
ORCL
Oracle CORPEVP and Chief Legal Officer of Oracle, Stuart Levey, reports acquisition of dividend equivalents accrued from restricted stock units.
NYSE
ORCL
Oracle CORPDirector George H. Conrades exercised stock options to acquire 22,500 shares of Oracle common stock at $43.49 per share on April 21, 2025.
NYSE
ORCL
Oracle CORPForm 4: Oracle Corp. Vice Chairman Jeffrey Henley Reports Transfer of Shares to Community Property Trust
Jeffrey Henley, Vice Chairman of Oracle Corp., reported a transfer of shares previously held by a GRAT to the Henley Community Property Trust.
NYSE
ORCL
Oracle CORPDirector Leon Panetta exercised stock options and sold shares of Oracle Corp on April 11, 2025.
NYSE
ORCL
Oracle CORPDirector Naomi Seligman sold 2,000 shares of Oracle stock at $145.81 on April 2, 2025.
NYSE
ORCL
Oracle CORPDirector Michael J. Boskin reported purchasing Oracle shares in February and March 2021, increasing his direct and indirect holdings.
NYSE
ORCL
Oracle CORPDirector Charles Moorman IV reports the acquisition of Oracle shares through a recent transaction.
NYSE
ORCL
Oracle CORPOracle's Chief Corporate Architect, Edward Screven, acquired restricted stock units through dividend equivalents, as reported in a recent SEC filing.
NYSE
ORCL
Oracle CORPOracle's Executive Vice President and Chief Legal Officer, Stuart Levey, acquired 170,383 restricted stock units on January 23, 2025, representing deferred dividend equivalents.
NYSE
ORCL
Oracle CORPOracle's CEO, Safra Catz, exercised stock options and sold a significant number of shares between January 22nd and January 24th, 2025, under a pre-arranged 10b5-1 trading plan.